No significant progress on covid. Waiting on PK data from MND. They are focusing their very limited resources on MND, dogs and Epichem. I asked the mouse trial and they said it was not a focus point at the moment. I am not 100% sure if it is in progress, done or not started.
They have been clear about MND phase 1 before covid. Another one liner - “we are no GSK” so we have a limit to what we can do.
I know some are unsatisfied with this but I am more interested in the broad spectrum antiviral plus minimal dilution anyway so have no issues with their priorities and sequencing.
adreamer
PAA Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)